Profile WellSky serves 20,000+ client sites Deal CarePort cost $1.35 billion Network 35% of U.S. post-acute transitions AI Up to 50% less documentation time

Company profile / Health technology

WellSky Put a $1.35 Billion Bridge Between the Hospital and Home

The former Mediware spent years assembling the overlooked machinery of post-acute care. Now its biggest test is turning a cabinet of specialist software into one intelligent network - without making care teams learn another disconnected tool.

Advertisement

A hospital discharge looks like an ending on a billing statement. In real life it is a relay exchange. A patient may need a skilled-nursing bed, oxygen, a home-health nurse, medication, transport and a payer authorization - preferably before anyone loses the referral in a fax queue. WellSky has built a large healthcare software business around that awkward moment when one institution says goodbye and several others must say hello.

The Overland Park, Kansas, company sells software, analytics and services to more than 20,000 client sites. The list is almost comically broad: hospital systems, home-health agencies, hospices, personal-care providers, blood banks, cell-therapy laboratories, pharmacies, rehabilitation teams, government offices and human-services nonprofits. This is not a consumer wellness brand. It is backstage infrastructure - the screens, rules and handoffs that keep care moving when the patient has left the bright center of the health system.

20K+client sites
35%of U.S. post-acute transitions touched by CarePort
$1.35BCarePort purchase price

The product is the handoff

WellSky’s catalog is easier to understand if you stop looking for one flagship app. Home Health manages referrals, clinical records, visits, billing and analytics. CareTend handles the peculiar operational puzzle of home infusion and specialty pharmacy. Blood Management tracks donors, testing, inventory, transfusion and biotherapy workflows. Human and Social Services software manages cases and community resources. CarePort coordinates referrals and follows patients across settings.

The common unit is not a hospital, a diagnosis or even a patient record. It is work crossing a boundary. A discharge planner needs to find a provider. A provider needs enough clinical and insurance information to accept. A payer needs to authorize. A field clinician needs the latest record. Management needs to know whether the patient actually arrived and what happened next. Generic office software is poor at this. Acute-care electronic health records are not designed to own every step outside the hospital. WellSky lives in that gap.

The WellSky bridge
Sending side

Hospitals and payers discharge, authorize, refer and monitor patients.

Receiving side

Home health, hospice, skilled nursing and community providers accept and deliver care.

A WellSky Home Health clinical assessment screen with a table of required sections and status markers
THE GLAMOUR SHOT, HEALTHCARE EDITION: a structured assessment where every green check means one less mystery waiting in the chart.

A platform assembled with a shopping cart

The company traces its roots to Mediware, founded in 1980 to serve specialized healthcare workflows. TPG Capital acquired it in 2016 and accelerated a buy-and-build strategy. The decisive early move was Kinnser Software in 2017. Kinnser brought more than 4,000 home-health, hospice and private-duty providers, plus a strong Austin base. Terms were not disclosed. Mediware became WellSky in 2018, a name roomy enough for a company no longer content to be a shelf of clinical programs.

Then came more adjacency. ClearCare extended the company into personal care. Healthify added social-care coordination. CarePort, acquired from Allscripts at the end of 2020, was the loudest purchase: $1.35 billion in cash, more than 13 times trailing revenue and roughly 21 times adjusted EBITDA. What did that price buy? Hundreds of hospital relationships, thousands of post-acute providers and a privileged view of where patients go after discharge.

CarePort was not merely another app. It was traffic control for the road WellSky’s other customers already traveled.The strategic logic behind the $1.35 billion deal

The capital structure changed alongside the product map. TPG reinvested in 2020 and Leonard Green & Partners joined as a new capital partner; the firms did not disclose the recapitalization’s price or WellSky’s valuation. The company is private, so its current revenue and profit are not published. A 2018 state bid response offers a useful old snapshot: $266 million of pro forma trailing revenue, $113 million of adjusted EBITDA and 83 percent recurring revenue in the referenced quarter. Supplied company data now estimates annual revenue around $600 million, but that number is not audited public guidance.

The commercial engine is classic vertical enterprise software with extra gears. Customers sign contracts for cloud access or licensed software, then may buy implementation, support, training and professional services. WellSky also sells coding, billing, revenue-cycle and strategic consulting work. Prices are generally quoted rather than posted, which makes sense when one buyer is a local home-care agency and another is a national health system. A public master agreement says professional services can be charged through an order form or at standard time-and-materials rates. The result is a mix of recurring software revenue and labor-backed services that can make the software harder to replace.

Customers are buying less reinvention than relief. A home-health operator can use one vendor for intake, the clinical record, mobile visits, compliance, revenue cycle and performance analytics. A payer can route members toward in-network post-acute providers and watch what happens after the handoff. A blood center can track a product from donor through testing, inventory and final disposition. In each case, the economic promise is similar: fewer manual steps, fewer denials, faster decisions and more usable capacity from scarce clinical staff. WellSky is strongest where operations are too specific for horizontal software and too distributed for a hospital system to manage alone.

The first thing to fail is context

WellSky does not publish a tidy postmortem naming the first product that failed or the meeting that changed management’s mind. The operational failure it repeatedly targets is clearer: context disappears at the handoff. Referrals arrive through multiple channels. Records are long. Medication lists need reconciliation. Staff chase authorization. A patient can be technically discharged while oxygen, transport or home care remains unresolved.

That is why CarePort mattered and why the recent product work is about intake, summaries and real-time visibility. It is also why WellSky’s differentiation is broader than feature count. A home-health startup can make a cleaner scheduling screen. An acute-care EHR company can add a discharge module. WellSky’s advantage is the installed network on both sides of the transition, combined with domain depth in the receiving settings. Its weakness is the mirror image: products acquired across decades can behave like a cabinet of systems unless data, identity and workflow genuinely connect.

The network underneath the pitch
Hospitals
2,000
Agencies
9,100
Client sites
20K+

AI with a timesheet

WellSky’s most persuasive AI story begins after dinner. Clinicians often finish documentation at home, a habit the company calls “pajama time.” Across home-based and specialty care, WellSky says its systems support more than 100 million forms a year. That is an enormous pile of constrained, repetitive work - and a better target for automation than a chat box looking for a purpose.

A 2024 Google Cloud partnership brought secure data tools, machine learning and Vertex AI into the plan. SkySense AI now includes Scribe for ambient documentation, Extract for pulling structured information such as medications from records, and Summarize for condensing charts. The design detail that matters is placement: these tools sit inside the clinical workflow and patient record. Extract keeps a clinician in the loop before medication data is approved. That is slower than blind automation and far more sensible in a regulated setting.

The early measurements are specific enough to be interesting. WellSky reports up to a 50 percent reduction in documentation time, 22.4 percent less after-hours charting and 19.2 percent faster submission. At Unison Health Services, 35 clinicians used the technology for more than 5,400 visits in five months and reported saving 15 to 20 minutes per chart. By mid-2026, WellSky said Scribe was live at more than 400 agencies. These are company-reported outcomes, not a universal guarantee, but they give buyers something better than an “AI-powered” sticker.

The practical question is what happens when the transcript is messy, the source record conflicts with itself or a patient’s living room is noisy. WellSky’s answer cannot be that the model is clever. It must be traceability, review and a safe return to manual work. Its medication-extraction architecture points in that direction by showing the clinician what was pulled and requiring approval. The approach may reduce typing; it does not transfer clinical accountability to the machine. That boundary is a feature, not an embarrassment.

What the reader can steal

WellSky’s playbook is available to any vertical-software operator, though the network is not. First, choose workflows where general-purpose tools break under regulation and specialist language. Second, expand through the path work already travels: referral to intake, intake to care, care to reimbursement. Third, put automation inside the task instead of asking users to visit a separate AI destination. Finally, measure the returned minutes. “Faster documentation” is marketing; 15 minutes per chart can become staffing capacity, earlier submissions and fewer laptops glowing at 10 p.m.

The copyable part
  • Buy or build adjacent workflow, not merely adjacent logos.
  • Own the handoff where data loses context and responsibility becomes fuzzy.
  • Keep a qualified human at the approval point for consequential AI output.
  • Sell time returned, errors avoided and work completed - not model vocabulary.

The approach has conditions. It works when customers share referrals, records or reimbursement dependencies; when the vendor can integrate with the systems already in place; and when recurring workflow value justifies enterprise implementation. It works poorly when an acquisition remains a separate login, when organizations will not share data, when buyers lack change-management capacity or when a generic platform is already good enough. Network effects are also fragile if participation feels like lock-in rather than coordination.

WellSky now sits between focused post-acute vendors such as Netsmart, MatrixCare, Axxess and Homecare Homebase, and broad health-system platforms such as Epic and Oracle Health. Its market position is neither lightweight SaaS nor the hospital’s central EHR. It is a sprawling operating layer for the lower-acuity, home-based and community care economy - software for the part of healthcare that starts when the elevator doors close behind the discharged patient.

Keep going

See the company’s current product language, engineering work and demonstrations directly.